Business Context and Reporting Period
Company: Translational Development Acquisition Corp. (TDAC)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Model: Cayman Islands exempted company (Special Purpose Acquisition Company or "SPAC") formed to effect a merger or business combination with one or more target businesses. The company has no operations other than organizational activities and the preparation for its Initial Public Offering (IPO).
Key Financial Metrics
| Metric | Value (2024) | Notes |
|---|---|---|
| Revenue | $0 | No operating revenues generated to date. |
| Net Loss | $(71,012) | Consists of operating costs of $196,358 offset by unrealized gain on trust securities of $125,346. |
| Cash and Cash Equivalents | $438,174 | Held outside the Trust Account as of December 31, 2024. |
| Investments in Trust Account | $174,350,346 | Includes $174,225,000 deposited at IPO plus interest/dividends earned. |
| Total Assets | $175,000,579 | |
| Total Liabilities | $6,247,803 | Includes $6,037,500 deferred underwriting fee. |
| Shareholders' Deficit | $(5,597,570) | |
| Shares Outstanding | 17,250,000 Class A (Public); 4,657,500 Class B (Founder) | Class A shares are subject to possible redemption. |
Material Changes vs. Prior Period
- Capital Raise: On December 24, 2024, the company consummated its IPO of 17,250,000 Units at $10.00 per unit, generating gross proceeds of $172,500,000. This includes the full exercise of the underwriter's over-allotment option.
- Private Placement: Simultaneously with the IPO, the company sold 7,075,000 Private Placement Warrants for $7,075,000.
- Trust Account: A total of $174,225,000 was deposited into a U.S.-based trust account. As of year-end, the balance grew to $174,350,346 due to interest income.
- Profitability: The company reported a net loss of $71,012 for 2024, a significant improvement from the $485,550 net loss in 2023, primarily due to the recognition of unrealized gains on trust securities.
- Debt: The company repaid a $800,000 promissory note to the Sponsor in full on December 31, 2024. No working capital loans were outstanding at year-end.
Guidance, Outlook, and Risks
- Completion Window: The company has 18 months from the IPO closing (until June 24, 2026) to consummate an initial business combination. If unsuccessful, the company will liquidate and redeem public shares.
- Redemption Rights: Public shareholders may redeem shares for a pro-rata portion of the Trust Account (initially $10.10 per share, plus interest). The Sponsor and officers have waived redemption rights for their founder shares.
- Liquidity: Management believes funds available outside the Trust Account ($438,174) plus potential working capital loans from the Sponsor are sufficient to sustain operations for at least one year.
- Deferred Fees: A deferred underwriting fee of $6,037,500 ($0.35 per unit) is payable only upon the successful completion of a business combination.
- Risks: Key risks include the inability to complete a business combination, potential claims against the Trust Account by creditors (though the Sponsor has agreed to indemnify the Trust Account up to certain limits), and geopolitical instability affecting global markets.
Investor Verification Checklist
- Trust Account Balance: Verify the current balance of the Trust Account and the per-share redemption value, which may fluctuate with interest rates.
- Extension Provisions: Review the company's charter for specific terms regarding shareholder votes required to extend the 18-month completion window.
- Sponsor Indemnity: Assess the financial capacity of the Sponsor (TDAC Partners LLC) to fulfill its indemnification obligations if third-party claims reduce the Trust Account below $10.10 per share.
- Related Party Transactions: Monitor the $10,000 monthly administrative fee paid to the Sponsor and any potential working capital loans that may convert to warrants.
- Target Selection: Evaluate the management team's track record and the specific criteria for target businesses, noting the lack of a specific target as of the filing date.